A Phase I Clinical Study of Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2017.03.234
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2017
Authors
Publisher
Elsevier BV